Sakar Healthcare Limited

NSEI:SAKAR Voorraadrapport

Marktkapitalisatie: ₹6.4b

Sakar Healthcare Beheer

Beheer criteriumcontroles 3/4

De CEO Sakar Healthcare is Sanjay Shah, benoemd in Feb2015, heeft een ambtstermijn van 9.75 jaar. bezit rechtstreeks 0% van de aandelen van het bedrijf, ter waarde ₹ 29.42K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.1 jaar en 4.2 jaar.

Belangrijke informatie

Sanjay Shah

Algemeen directeur

₹4.8m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO9.8yrs
Eigendom CEO0.0005%
Management gemiddelde ambtstermijn4.1yrs
Gemiddelde ambtstermijn bestuur4.2yrs

Recente managementupdates

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02
Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Recent updates

Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think

Oct 30
Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Dec 28
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Aug 05
Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Mar 29
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors

Jan 31
Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors

Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?

Dec 01
Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Jul 13
Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Mar 26
Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting

Jul 01
With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Mar 23
Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02
Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Feb 08
Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Jan 10
Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Dec 14
Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

Nov 22
Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

Analyse CEO-vergoeding

Hoe is Sanjay Shah's beloning veranderd ten opzichte van Sakar Healthcare's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

₹124m

Jun 30 2024n/an/a

₹112m

Mar 31 2024₹5mn/a

₹117m

Dec 31 2023n/an/a

₹125m

Sep 30 2023n/an/a

₹144m

Jun 30 2023n/an/a

₹127m

Mar 31 2023₹5mn/a

₹128m

Dec 31 2022n/an/a

₹178m

Sep 30 2022n/an/a

₹139m

Jun 30 2022n/an/a

₹144m

Mar 31 2022₹5mn/a

₹152m

Dec 31 2021n/an/a

₹80m

Sep 30 2021n/an/a

₹97m

Jun 30 2021n/an/a

₹118m

Mar 31 2021₹2mn/a

₹107m

Dec 31 2020n/an/a

₹118m

Sep 30 2020n/an/a

₹122m

Jun 30 2020n/an/a

₹106m

Mar 31 2020₹2m₹2m

₹96m

Dec 31 2019n/an/a

₹88m

Sep 30 2019n/an/a

₹86m

Jun 30 2019n/an/a

₹78m

Mar 31 2019₹2m₹2m

₹67m

Compensatie versus markt: De totale vergoeding ($USD 56.93K ) Sanjay } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 42.72K ).

Compensatie versus inkomsten: De vergoeding van Sanjay is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Sanjay Shah (65 yo)

9.8yrs

Tenure

₹4,800,000

Compensatie

Mr. Sanjay Surendra Shah has been Managing Director of Sakar Healthcare Limited since February 1, 2015. Mr. Shah serves as an Executive Director of Sakar Healthcare Limited since March 26, 2004 and serves...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Sanjay Shah
Chairman & MD9.8yrs₹4.80m0.00046%
₹ 29.4k
Aarsh Shah
Joint MD & Executive Director12.4yrs₹3.60m0.000060%
₹ 3.8k
Sunil Marathe
Technical Director & Whole Time Directorless than a year₹1.20mgeen gegevens
Dharmesh Thaker
Chief Financial Officer3.1yrsgeen gegevensgeen gegevens
Bharat Soni
Company Secretary & Compliance Officer4.1yrsgeen gegevensgeen gegevens

4.1yrs

Gemiddelde duur

34yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van SAKAR wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Sanjay Shah
Chairman & MD20.7yrs₹4.80m0.00046%
₹ 29.4k
Aarsh Shah
Joint MD & Executive Director12.4yrs₹3.60m0.000060%
₹ 3.8k
Sunil Marathe
Technical Director & Whole Time Directorless than a year₹1.20mgeen gegevens
Vishalakshi Chandramouli
Non-Executive Non-Independent Director1.2yrsgeen gegevensgeen gegevens
Shailesh Patel
Non-Executive Independent Director9.6yrsgeen gegevensgeen gegevens
Prashant Srivastav
Independent Non-Executive Director9.6yrsgeen gegevensgeen gegevens
Hemendrakumar Shah
Independent Non-Executive Director4.2yrsgeen gegevensgeen gegevens
Khyati Shah
Non-Executive Independent Directorless than a yeargeen gegevensgeen gegevens
Jignesh Parikh
Non-Executive Independent Directorless than a yeargeen gegevensgeen gegevens

4.2yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SAKAR wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).